# Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion

> **NCT04872283** · PHASE3 · UNKNOWN · sponsor: **Rothman Institute Orthopaedics** · enrollment: 140 (estimated)

## Conditions studied

- Ketorolac
- Joint Fusion

## Interventions

- **PROCEDURE:** great toe (1st metatarsophalangeal joint) fusion
- **DRUG:** IV Ketorolac
- **DRUG:** Ketorolac Pill
- **DRUG:** 5/325mg Oxycodone-Acetaminophen
- **DRUG:** Aspirin 81Mg Ec Tab

## Key facts

- **NCT ID:** NCT04872283
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-23
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04872283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04872283, "Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04872283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*